Results 11 to 20 of about 160,479 (262)

Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules [PDF]

open access: yesStatistics in Biopharmaceutical Research, 2020, 2020
Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis.
Friede, Tim   +2 more
core   +2 more sources

Pembersihan Luka Dermatitis Atopik Dengan Cairan Normal Salin [PDF]

open access: yesJurnal Keperawatan, 2014
PEMBERSIHAN LUKA DERMATITIS ATOPIK DENGANCAIRAN NORMAL SALIN(Atopic Dermatitis Wound Cleaning with Normal Saline)Tavip Dwi WahyuniPoltekkes Kemenkes Malange-mail: dwitavip@yahoo.comABSTRAKDermatitis atopik merupakan penyakit peradangan kronis yang ...
Wahyuni, T. D. (Tavip)
core   +3 more sources

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

open access: yesActa Dermato-Venereologica, 2023
Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes   +8 more
doaj   +1 more source

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

open access: yesActa Dermato-Venereologica, 2021
Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort
Lieneke F.M. Ariëns   +9 more
doaj   +1 more source

Oral food challenges in children [PDF]

open access: yesKorean Journal of Pediatrics, 2011
Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum   +9 more
doaj   +1 more source

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

open access: yesClinical and Translational Allergy, 2023
Background The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity ...
Roselie Achten   +13 more
doaj   +1 more source

Prevalence of Isotretinoin Therapy in Adolescents and Young Adults With and Without Atopic Dermatitis: A Nationwide Prescription-based Population Study

open access: yesActa Dermato-Venereologica, 2023
Although isotretinoin has anti-inflammatory and immunomodulatory properties, it can exacerbate atopic dermatitis. National estimates of the extent to which patients with atopic dermatitis are affected by severe acne and isotretinoin tolerability are ...
Cathrine H. Mohn   +4 more
doaj   +1 more source

Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan

open access: yesActa Dermato-Venereologica, 2021
Atopic dermatitis has a substantial impact on work and activity impairment according to studies from Western communities. Prospective studies of work productivity and activity impairment in Asian patients with atopic dermatitis are lacking.
Tom C. Chan   +4 more
doaj   +1 more source

Psychological Stress in Parents of Children with Atopic Dermatitis: A Cross-sectional Study from the Korea National Health and Nutrition Examination Survey

open access: yesActa Dermato-Venereologica, 2023
Atopic dermatitis is a chronically relapsing inflammatory skin condition that has profound impacts on quality of life of patients and their family.
Hyun Ji Lee   +5 more
doaj   +1 more source

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial

open access: yesDermatology and Therapy, 2020
Introduction Patients with atopic dermatitis (AD) have a greater risk of conjunctivitis and other ocular surface disorders than the general population. We evaluated the burden of ocular surface disorders and related symptoms prior to treatment initiation
Jonathan Weyne   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy